Nomura Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $57.7M | Sell |
160,692
-13,570
| -8% | -$4.15M | 0.12% | 165 |
|
|
2026
Q1 | $43.7M | Buy |
174,262
+19,760
| +13% | +$4.92M | 0.11% | 192 |
|
|
2025
Q4 | $42.5M | Sell |
154,502
-7,219
| -4% | -$1.97M | 0.11% | 201 |
|
|
2025
Q3 | $42.4M | Sell |
161,721
-28,506
| -15% | -$6.93M | 0.11% | 198 |
|
|
2025
Q2 | $41.6M | Buy |
190,227
+58,445
| +44% | +$12.5M | 0.11% | 203 |
|
|
2025
Q1 | $29.5M | Sell |
131,782
-8,006
| -6% | -$2.21M | 0.09% | 236 |
|
|
2024
Q4 | $45.8M | Buy |
139,788
+9,443
| +7% | +$2.97M | 0.14% | 167 |
|
|
2024
Q3 | $39.1M | Buy |
130,345
+23,850
| +22% | +$7.3M | 0.12% | 192 |
|
|
2024
Q2 | $35.1M | Sell |
106,495
-39
| -0% | -$13.8K | 0.12% | 181 |
|
|
2024
Q1 | $42.2M | Buy |
106,534
+19,496
| +22% | +$7.21M | 0.15% | 152 |
|
|
2023
Q4 | $30.6M | Sell |
87,038
-1,129
| -1% | -$400K | 0.13% | 195 |
|
|
2023
Q3 | $33.1M | Buy |
88,167
+12,673
| +17% | +$4.9M | 0.16% | 159 |
|
|
2023
Q2 | $28.9M | Sell |
75,494
-9,836
| -12% | -$3.51M | 0.13% | 181 |
|
|
2023
Q1 | $29.6M | Buy |
85,330
+12,575
| +17% | +$3.67M | 0.16% | 150 |
|
|
2022
Q4 | $17.1M | Buy |
72,755
+17,237
| +31% | +$4.08M | 0.1% | 230 |
|
|
2022
Q3 | $13.7M | Buy |
55,518
+12,033
| +28% | +$3.67M | 0.09% | 259 |
|
|
2022
Q2 | $13.1M | Buy |
43,485
+6,909
| +19% | +$2.25M | 0.08% | 259 |
|
|
2022
Q1 | $15M | Buy |
36,576
+1,778
| +5% | +$696K | 0.08% | 252 |
|
|
2021
Q4 | $16.3M | Sell |
34,798
-413
| -1% | -$178K | 0.08% | 236 |
|
|
2021
Q3 | $14.9M | Buy |
35,211
+517
| +1% | +$218K | 0.08% | 234 |
|
|
2021
Q2 | $12.5M | Buy |
34,694
+4,396
| +15% | +$1.45M | 0.07% | 273 |
|
|
2021
Q1 | $8.54M | Buy |
30,298
+9,868
| +48% | +$2.82M | 0.05% | 323 |
|
|
2020
Q4 | $5.79M | Buy |
20,430
+926
| +5% | +$260K | 0.04% | 386 |
|
|
2020
Q3 | $5.36M | Buy |
19,504
+123
| +0.6% | +$32.6K | 0.04% | 358 |
|
|
2020
Q2 | $4.4M | Buy |
19,381
+4,791
| +33% | +$941K | 0.04% | 385 |
|
|
2020
Q1 | $2.22M | Buy |
14,590
+2,810
| +24% | +$433K | 0.02% | 478 |
|
|
2019
Q4 | $1.77M | Buy |
11,780
+7,600
| +182% | +$1.11M | 0.02% | 657 |
|
|
2019
Q3 | $593K | Sell |
4,180
-4,060
| -49% | -$559K | 0.01% | 853 |
|
|
2019
Q2 | $1.03M | Hold |
8,240
| – | – | 0.01% | 770 |
|
|
2019
Q1 | $908K | Hold |
8,240
| – | – | 0.01% | 777 |
|
|
2018
Q4 | $808K | Buy |
+8,240
| New | +$894K | 0.01% | 747 |
|
|
2018
Q3 | – | Sell |
-11,240
| Closed | -$1.12M | – | 958 |
|
|
2018
Q2 | $1.12M | Hold |
11,240
| – | – | 0.01% | 714 |
|
|
2018
Q1 | $992K | Buy |
+11,240
| New | +$1.05M | 0.01% | 742 |
|
|
2017
Q1 | – | Sell |
-240
| Closed | -$20K | – | 1277 |
|
|
2016
Q4 | $20K | Buy |
+240
| New | +$18.9K | ﹤0.01% | 1348 |
|
Other funds holding WST
GIM
Nomura Asset Management's WST Position: Q2 2026 in Review
Nomura Asset Management reduced its West Pharmaceutical (WST) stake by 7.8% in Q2 2026, selling an estimated $4.15M and leaving 160,692 shares worth $57.7M. The position accounts for 0.12% of the portfolio, ranked #165.
Nomura Asset Management first reported a position in WST in Q4 2016 and has held it in 34 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.
- Nomura Asset Management held 160,692 shares of West Pharmaceutical worth $57.7M as of Q2 2026.
- Nomura Asset Management sold 13,570 West Pharmaceutical shares in Q2 2026, an estimated $4.15M.
- West Pharmaceutical made up 0.12% of Nomura Asset Management's portfolio in Q2 2026, its #165 holding.
- Nomura Asset Management first reported a position in West Pharmaceutical in Q4 2016 and has held it in 34 quarters since.
- 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.
Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.